Additionally, serum MUC5AC ≥ 14 ng/mL was associated with lymph-node metastasis, tumour stage (IVb) and a worse prognosis in BTC patients who underwent surgery, compared with patients with lower levels of this mucin [155]. Here, MUC5AC is linked to metastatic malignant neoplasm in the lymph nodes.